Source: Eur Respir J, 57 (6) 2004354; 10.1183/13993003.04354-2020



Rating:

Share or cite this content

Citations should be made in the following way:
Carmel Bergbaum, Chinthaka B. Samaranayake, Alex Pitcher, Emma Weingart, Thomas Semple, Maria Kokosi, Athol U. Wells, David Montani, Konstantinos Dimopoulos, Colm McCabe, Aleksander Kempny, Carl Harries, Elizabeth Orchard, S. John Wort, Laura C. Price. A case series on the use of steroids and mycophenolate mofetil in idiopathic and heritable pulmonary veno-occlusive disease: is there a role for immunosuppression?. Eur Respir J, 57 (6) 2004354; 10.1183/13993003.04354-2020

Member's Comments

No comment yet.

Related content which might interest you: Impact of mycophenolate mofetil on lung function in chronic hypersensitivity pneumonitis and connective tissue disease related-ILD Source: Virtual Congress 2020 – Natural history and management of interstitial lung diseases of known cause Year: 2020 Mycophenolate mofetil and azathioprine in chronic hypersensitivity pneumonitis Source: International Congress 2016 – Orphan diseases I Year: 2016 Idiopathic pulmonary fibrosis: efficacy of complex immunosuppressive therapy by cyclophosphamide and corticosteroids Source: Annual Congress 2009 - Various backgrounds in diffuse parenchymal lung disease Year: 2009 Effect and safety of mycophenolate mofetil in idiopathic pulmonary fibrosis. A retrospective study Source: Annual Congress 2011 - New insights in the treatment of idiopathic pulmonary fibrosis Year: 2011 Pulmonary alveolar proteinosis due to mycophenolate and cyclosporine combination therapy in a renal transplant recipient Source: Annual Congress 2012 - Respiratory manifestations of systemic disease: a holistic approach Year: 2012 Case series reporting the effectiveness of mycophenolate mofetil in treatment-resistant asthma Source: Eur Respir J 2013; 42: 1134-1137 Year: 2013 Safety and effectiveness of mycophenolate mofetil in interstitial lung diseases Source: Virtual Congress 2021 – News in treatment and diagnosis of idiopathic interstitial pneumonia Year: 2021 Can mycophenolate mofetil 15 mg/kg/day attenuate experimental pulmonary fibrosis in rats? Source: Annual Congress 2009 - A wide spectrum of idiopathic pulmonary fibrosis Year: 2009 Azathioprine and low-dose prednisone in chronic pulmonary sarcoidosis Source: Eur Respir J 2005; 26: Suppl. 49, 268s Year: 2005 Mycophenolate mofetil: an effective corticosteroid-sparing drug in steroid-dependent asthma Source: Eur Respir J 2005; 26: Suppl. 49, 49s Year: 2005 Churg-Strauss syndrome treated with mycophenolate mofetil Source: Eur Respir J 2002; 20: Suppl. 38, 65s Year: 2002 Comparison of post renal transplant tuberculosis cases receiving conventional immunosupressive therapy and mycophenolat mofetil (MMF) and/or tacrolimus (TAC) Source: Eur Respir J 2003; 22: Suppl. 45, 157s Year: 2003 Results of switch from mycophenolate mofetil to azathioprin after lung transplantation Source: Eur Respir J 2004; 24: Suppl. 48, 178s Year: 2004 Mycophenolate mofetil (MMF) rescue therapy in lung transplantation: results and pharmacokinetics Source: Eur Respir J 2002; 20: Suppl. 38, 348s Year: 2002 Efficacy and toxicity of azathioprine plus corticosteroids in 32 patients with chronic persistent sarcoidosis Source: Eur Respir J 2004; 24: Suppl. 48, 712s Year: 2004 Use of mycophenolate mofetil for the treatment of hypersensitivity pneumonitis> Source: Virtual Congress 2020 – Natural history and management of interstitial lung diseases of known cause Year: 2020 Methotrexate vs azathioprine in chronic sarcoidosis Source: Annual Congress 2012 - Sarcoidosis Year: 2012 Mycophenolate mofetil reduces alveolar inflammation and acute rejection and improves overall outcome after lung transplantation Source: Eur Respir J 2006; 28: Suppl. 50, 724s Year: 2006 Intravenous pulse doses of high-dose corticosteroid and cyclophosphamide in acute exacerbation of idiopathic pulmonary fibrosis Source: International Congress 2015 – IPF: from bench to bedside Year: 2015 A retrospective review to assess the effect of prednisolone and azathioprine on usual interstitial pneumonia disease progression Source: Eur Respir J 2006; 28: Suppl. 50, 826s Year: 2006